Clinical Trial Update: Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis [Phase 1]

View source ↗

Summary

Pilot Phase 1 trial evaluating Tofacitinib for corticosteroid-dependent sarcoidosis; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis
• Sarcoidosis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Sarcoidosis, Pulmonary, Sarcoidosis Lung | Phase 1 | Status: COMPLETED | Results posted: 2022-02-18